<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01120678</url>
  </required_header>
  <id_info>
    <org_study_id>13987</org_study_id>
    <nct_id>NCT01120678</nct_id>
  </id_info>
  <brief_title>Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay</brief_title>
  <official_title>Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wallace H. Coulter Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether analysis of specific serum biomarkers will
      improve the diagnosis of late onset neonatal sepsis and to determine the correlation between
      plasma levels of specific cytokines and bacteremia in NICU patients &gt;3 days of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All infants in the Newborn Intensive Care Unit greater than three days old that had blood
      cultures sent were eligible for this study. Left-over blood from the time at blood culture
      was collected for research purposes. Study personnel separated the serum and stored samples
      at -80 degrees until analysis. Samples were analyzed in batch for neonatal sepsis biomarkers
      using an antibody-coated microsphere assay with dual laser detection. Clinical information
      collected included symptoms prompting the blood culture, CBC and culture results, and
      antibiotic therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cytokine response</measure>
    <time_frame>Within the first twenty-four hours after blood cultures are obtained.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate characteristics</measure>
    <time_frame>Within twenty-fours pre and post blood culture.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Late Onset Neonatal Sepsis</condition>
  <arm_group>
    <arm_group_label>Neonates assessed for sepsis.</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples of whole blood were obtained and processed to collect and retain only serum.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Infants in the Newborn Intensive Care Unit greater than three days of age undergoing sepsis
        evaluation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NICU patients &gt; 3 days of age

        Exclusion Criteria:

          -  less than 3 days old or no waste blood available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Fairchild, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Neonatal Intensive Care Unit</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2010</study_first_submitted>
  <study_first_submitted_qc>May 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2010</study_first_posted>
  <last_update_submitted>March 4, 2011</last_update_submitted>
  <last_update_submitted_qc>March 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2011</last_update_posted>
  <responsible_party>
    <name_title>Karen Fairchild, MD</name_title>
    <organization>University of Virginia School of Medicine</organization>
  </responsible_party>
  <keyword>cytokines</keyword>
  <keyword>late-onset neonatal sepsis</keyword>
  <keyword>neonatal sepsis</keyword>
  <keyword>diagnosis of sepsis</keyword>
  <keyword>bacteremia</keyword>
  <keyword>blood culture</keyword>
  <keyword>clinical sepsis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

